Aquestive Therapeutics, Inc. Share Price
NASDAQ: AQST | Small CapAquestive Therapeutics, Inc. Stock Performance
Aquestive Therapeutics, Inc. Share Price Today
As of 31 October 2026, Aquestive Therapeutics, Inc.'s share price is $3.90. The stock opened at $4.03, compared to its previous close of $4.03. During today's trading session, Aquestive Therapeutics, Inc.'s share price traded between $3.87 and $4.04, with an average price of $3.95. Over the past 52 weeks, the stock has recorded a high of $6.92 and a low of $2.93. In terms of performance, Aquestive Therapeutics, Inc.'s share price has declined by 4.87% over the last six months and is down 42.66% on a year-on-year basis.
Aquestive Therapeutics, Inc. Share Price Chart
Aquestive Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
Aquestive Therapeutics, Inc. Annual Profit & Loss
All figures in USD
About Aquestive Therapeutics, Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
Aquestive Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $4.60 | $3.88 | -16.11% |
Sep 2026 | $5.13 | $4.63 | -10.11% |
Aug 2026 | $3.67 | $5.14 | +39.05% |
Jul 2026 | $4.26 | $3.70 | -11.38% |
Jun 2026 | $3.99 | $4.17 | +3.60% |
May 2026 | $4.13 | $4.03 | -1.83% |
Apr 2026 | $4.19 | $4.11 | -1.08% |
Mar 2026 | $4.02 | $4.15 | +2.98% |
Feb 2026 | $4.00 | $4.03 | +37.54% |
Jan 2026 | $6.57 | $2.93 | -54.57% |
Dec 2025 | $6.07 | $6.45 | +4.12% |
Nov 2025 | $6.69 | $6.20 | -9.03% |